DARPA research program support services
Active Awarded Last action
- Contract number
- HR001125FE019
- Awardee
-
The General Hospital Corporation UEI FLJ7DQKLL226
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $300,068
Award facts
- Contract value 51% obligated
-
- $300,068.00 Current, with exercised options
- $588,436.00 Potential, with all options
- Completion date 90% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02114, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $56,146 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $170,938 | |
| Original award | $72,984 |
About this award
The Defense Advanced Research Projects Agency (DARPA) awarded a $588,436 firm fixed-price task order to Massachusetts General Hospital (MGH), a Harvard Medical School affiliate and nonprofit academic medical center, under a $25 million Blanket Purchase Agreement (BPA) for DARPA Research Program Support Services. The work will be performed at MGH's Research Management Division in Boston, Massachusetts, with an ultimate completion date of December 18, 2026. This task order represents one of seven issued against the BPA as of June 2025, collectively totaling approximately $3.75 million. The BPA, effective August 21, 2024 through August 20, 2027, carries no small business set-aside designation and enables DARPA to procure specialized research and commercialization support services from one of the nation's premier biomedical research institutions.
Under this task order, MGH will deliver commercial accelerator support services encompassing clinical evaluations of emerging technologies, clinical trial protocol development, intellectual property validation, market analysis, go-to-market strategy development, and strategic business support. The work leverages MGH's extensive federal research credentials and infrastructure across multiple scientific domains including neuroscience, oncology, infectious diseases, and cardiovascular research. MGH regularly engages subcontractors such as Bridgewood Research Solutions LLC to support comprehensive clinical and commercial acceleration activities. This BPA structure reflects DARPA's strategic reliance on academic medical research institutions to advance innovative solutions with applications to national defense objectives while enabling flexible procurement of specialized research and development services.
Quick answers
Who was awarded contract HR001125FE019?
HR001125FE019 was awarded to The General Hospital Corporation by Defense Advanced Research Projects Agency (Department of Defense) on June 9, 2025.
How much is contract HR001125FE019 worth?
The government has obligated $300,068 on HR001125FE019. Its potential value, with all options, is $588,436.
Is contract HR001125FE019 an order under another contract?
Yes. HR001125FE019 is a BPA call under HR001124A0003, a blanket purchase agreement.
Was contract HR001125FE019 competed?
The extent of competition for HR001125FE019 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award